Search for: "Williams v. Pfizer Inc"
Results 1 - 20
of 71
Sort by Relevance
|
Sort by Date
19 Oct 2023, 8:59 am
[LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
30 Aug 2016, 2:33 pm
Wyeth, Inc., Dr. [read post]
30 Nov 2015, 3:34 am
, pens this post about the well-known and much-debated issue of the product plain packaging [on which see earlier Katposts here, here, here, and here].* Court of Appeal dismisses Rovi's claim construction attempt in battle with VirginA few days ago the Court of Appeal of England and Wales handed down its decision in Rovi Guides Inc v Virgin Media Ltd & Others [2015] EWCA Civ 1214. [read post]
25 Jun 2015, 5:00 am
Pfizer, Inc., 381 F. [read post]
21 Oct 2014, 9:59 pm
By Andrew Williams -- Anyone that has been monitoring the outcome of district court cases recently will be aware of the perils of not including sufficient information, or not timely supplementing, preliminary infringement or invalidity contentions required by many local patent rules. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
23 Jun 2014, 12:57 pm
” Matrixx Initiatives, Inc. v. [read post]
3 May 2014, 8:56 am
Pfizer, Inc., 196 F. [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
6 Feb 2014, 9:59 pm
By Andrew Williams -- The standard of review at the Federal Circuit is important. [read post]
17 Oct 2013, 5:00 am
Squibb & Sons, Inc. v. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
4 Sep 2013, 4:30 am
Pfizer, Inc., 2013 U.S. [read post]
23 Jan 2013, 1:02 am
Ass’n of the U.S., Inc. v. [read post]
23 Jan 2013, 1:02 am
Ass’n of the U.S., Inc. v. [read post]
16 Jan 2013, 4:30 am
Pfizer, Inc., 2013 U.S. [read post]
2 Oct 2012, 1:08 pm
Pfizer Inc. [read post]
9 Aug 2012, 5:00 am
Clarus Medical (laser) Deposition2005-07-11 Williams v. [read post]
27 Jul 2012, 12:40 pm
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
14 Jul 2012, 7:08 am
Philip Morris USA, Inc., 449 F. [read post]
